EAM Investors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-96,225
Closed -$3.07M 281
2024
Q1
$3.07M Buy
+96,225
New +$3.07M 0.48% 117